<qa>  What is the first prospective study?This will be the first prospective study where patients will be selected on the basis of two measures of the epidermal growth factor receptor EGFR pathway. The study will assess prospectively the efficacy of erlotinib as a single agent or intercalated with chemotherapy in highly selected patients with EGFR overexpression andor EGFR amplification. 